Regional News • Europe • European Union

EU to buy 300 million doses of Pfizer-BioNTech Covid-19 vaccine

The European Union will sign a fourth contract with the US pharmaceutical giant Pfizer and their German lab partner BioNTech to procure up to 300 million doses of their Covid-19 vaccine, if proven to be safe and effective against the virus.

"As a company founded in the heart of Europe, we are looking forward to supplying millions of people upon regulatory approval," so BioNTech's CEO Ugur Sahin in a statement Wednesday. On Tuesday, Sahin said on a call with reporters that said BioNTech's goal is to ramp up production of their vaccine candidate in the hopes of manufacture up to 1.3 billion doses by the end of 2021.

Highly edible human, designer of all things digital, co-founder of Pendect, creative native, constant wa/onderer, morse code lady, full-time dog pillow.
Card reviewed by: @christoph